1. Home
  2. XNCR vs SHLS Comparison

XNCR vs SHLS Comparison

Compare XNCR & SHLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNCR
  • SHLS
  • Stock Information
  • Founded
  • XNCR 1997
  • SHLS 1996
  • Country
  • XNCR United States
  • SHLS United States
  • Employees
  • XNCR N/A
  • SHLS N/A
  • Industry
  • XNCR Biotechnology: Pharmaceutical Preparations
  • SHLS Semiconductors
  • Sector
  • XNCR Health Care
  • SHLS Technology
  • Exchange
  • XNCR Nasdaq
  • SHLS Nasdaq
  • Market Cap
  • XNCR 1.1B
  • SHLS 1.1B
  • IPO Year
  • XNCR 2013
  • SHLS 2021
  • Fundamental
  • Price
  • XNCR $13.86
  • SHLS $10.47
  • Analyst Decision
  • XNCR Buy
  • SHLS Buy
  • Analyst Count
  • XNCR 11
  • SHLS 20
  • Target Price
  • XNCR $24.20
  • SHLS $8.26
  • AVG Volume (30 Days)
  • XNCR 1.5M
  • SHLS 7.7M
  • Earning Date
  • XNCR 11-06-2025
  • SHLS 11-04-2025
  • Dividend Yield
  • XNCR N/A
  • SHLS N/A
  • EPS Growth
  • XNCR N/A
  • SHLS N/A
  • EPS
  • XNCR N/A
  • SHLS 0.12
  • Revenue
  • XNCR $146,929,000.00
  • SHLS $400,354,000.00
  • Revenue This Year
  • XNCR $22.09
  • SHLS $18.14
  • Revenue Next Year
  • XNCR N/A
  • SHLS $14.78
  • P/E Ratio
  • XNCR N/A
  • SHLS $86.56
  • Revenue Growth
  • XNCR N/A
  • SHLS N/A
  • 52 Week Low
  • XNCR $6.92
  • SHLS $2.71
  • 52 Week High
  • XNCR $27.24
  • SHLS $11.36
  • Technical
  • Relative Strength Index (RSI)
  • XNCR 55.63
  • SHLS 59.70
  • Support Level
  • XNCR $12.17
  • SHLS $10.04
  • Resistance Level
  • XNCR $15.50
  • SHLS $11.36
  • Average True Range (ATR)
  • XNCR 1.15
  • SHLS 0.67
  • MACD
  • XNCR -0.12
  • SHLS -0.09
  • Stochastic Oscillator
  • XNCR 49.86
  • SHLS 44.29

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

About SHLS Shoals Technologies Group Inc.

Shoals Technologies Group is a provider of electrical balance of system solutions for solar energy projects, primarily in the United States. EBOS encompasses components that are necessary to carry electric current produced by solar panels to an inverter. The products are sold principally to engineering, procurement, and construction firms that build solar energy projects.

Share on Social Networks: